Triombrast (diatrizoic acid dihydrate) injection 60% 20 ml. s #5

$43.75

Manufactured in: Ukraine

Triombrast injection is a contrast medium that enhances imaging clarity in diagnostic procedures like CT scans and angiography, helping visualize organs and guide interventions for improved diagnostic accuracy and patient care.

SKU: MED8269 Category:

Description

Triombrast (diatrizoic acid dihydrate) Solution for Injection 60% 20 ml. Vials #5

Overview

Triombrast is a contrast medium used for diagnostic imaging procedures. Diatrizoic acid dihydrate, the active ingredient in this solution, enhances the visibility of specific areas of the body during imaging tests. It works by altering the way X-rays or other imaging techniques interact with tissues and organs, providing clearer images for healthcare providers to assess and diagnose various conditions.

Indications

The primary indications for Triombrast include:

  • Enhancement of contrast in diagnostic imaging studies such as CT scans, angiography, and other radiographic procedures.
  • Visualization of specific organs, blood vessels, or tissues for diagnostic purposes.
  • Assistance in guiding interventional procedures such as biopsies or drainage.

Dosage and Administration

Before administering Triombrast, healthcare providers should carefully review the dosage instructions and ensure proper handling of the solution. The recommended dosage may vary depending on the specific imaging procedure and the patient’s individual characteristics. It is essential to follow the prescribing healthcare provider’s instructions regarding dosage and administration.

Administration

Triombrast is intended for intravascular administration, which means it is injected directly into the bloodstream. The injection should be performed by a trained healthcare professional in a clinical setting equipped to handle potential allergic reactions or other adverse events that may occur during or after administration.

Precautions and Warnings

Before using Triombrast, it is crucial to consider the following precautions and warnings:

  • Inform the healthcare provider of any allergies, especially to contrast media or iodine-based products.
  • Discuss any existing medical conditions, such as kidney problems or thyroid disorders, that may influence the use of Triombrast.
  • Pregnant or breastfeeding women should inform their healthcare provider before undergoing imaging procedures involving contrast media.

Adverse Reactions

While Triombrast is generally well-tolerated, some patients may experience adverse reactions following administration. Common side effects may include:

  • Nausea
  • Vomiting
  • Headache
  • Flushing

In rare cases, allergic reactions or more severe adverse events such as anaphylaxis may occur. It is essential to monitor patients closely during and after administration for any signs of adverse reactions and take appropriate measures to address them promptly.

Storage and Handling

Triombrast should be stored according to the manufacturer’s instructions to maintain its stability and efficacy. Keep the vials in a cool, dry place away from direct sunlight and heat sources. Follow proper disposal procedures for any unused or expired medication to prevent environmental contamination.

Conclusion

Triombrast, with its active ingredient diatrizoic acid dihydrate, is a valuable contrast medium used in diagnostic imaging procedures. By enhancing the visibility of specific anatomical structures and tissues, this solution aids healthcare providers in making accurate diagnoses and guiding interventional treatments. When used according to the prescribed guidelines and with proper precautions, Triombrast can contribute to improved patient outcomes and overall healthcare quality.

Remember to consult your healthcare provider for personalized advice and recommendations regarding the use of Triombrast and other medical interventions.